CELU

3.74

18.73% 0.59

Vorhandelsmarkt: 3.60 -0.14 -3.74%

Celularity Inc (CELU)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$3.15

Offen:

$3.31

24-Stunden-Volumen:

1.01M

Relative Volume:

4.54

Marktkapitalisierung:

$89.57M

Einnahmen:

$48.20M

Nettoeinkommen (Verlust:

$-35.05M

KGV:

-2.3863

EPS:

-1.5673

Netto-Cashflow:

$-13.02M

1W Leistung:

+50.81%

1M Leistung:

+112.50%

6M Leistung:

+61.21%

1J Leistung:

+28.08%

1-Tages-Spanne:

$3.0567

$4.35

1-Wochen-Bereich:

$2.01

$4.35

52-Wochen-Spanne:

$1.06

$5.22

Celularity Inc Stock (CELU) Company Profile

Firmenname

Celularity Inc

Sektor

Healthcare (1161)

Branche

Biotechnology (653)

Telefon

(908) 768-2170

Adresse

170 PARK AVE, FLORHAM PARK

Mitarbeiter

123

Twitter

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

CELU's Discussions on Twitter

Vergleichen Sie CELU mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CELU Celularity Inc	3.74	59.39M	48.20M	-35.05M	-13.02M	-1.5673
VRTX Vertex Pharmaceuticals Inc	470.13	119.21B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	560.93	59.16B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.28	40.57B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	571.23	34.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	295.59	29.19B	3.81B	-644.79M	-669.77M	-6.24

Celularity Inc Stock (CELU) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-01-30	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2022-12-22	Herabstufung	Oppenheimer	Outperform → Perform
2022-06-22	Eingeleitet	H.C. Wainwright	Buy
2022-04-06	Herabstufung	Truist	Buy → Hold
2022-01-28	Eingeleitet	Oppenheimer	Outperform
2021-11-24	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Celularity Inc Aktie (CELU) Neueste Nachrichten

Jul 22, 2025

What drives Celularity Inc. Equity Warrant stock priceOutstanding capital appreciation - jammulinksnews.com

Jul 22, 2025

Is Celularity Inc. a good long term investmentConsistently high yield - jammulinksnews.com

Jul 22, 2025

What analysts say about Celularity Inc. Equity Warrant stockPhenomenal wealth increase - jammulinksnews.com

Jul 22, 2025

Celularity Finalizes Private Placement Agreement - TipRanks

Jul 22, 2025

Is Celularity Inc. Equity Warrant a good long term investmentBreakthrough financial growth - jammulinksnews.com

Jul 22, 2025

What drives Celularity Inc. stock priceExceptional risk-adjusted gains - jammulinksnews.com

Jul 22, 2025

What analysts say about Celularity Inc. stockTriple returns potential - jammulinksnews.com

Jul 22, 2025

Celularity Soared 23.8% Intraday, Could This Biotech Breakout Signal a New Bullish Era? - AInvest

Jul 22, 2025

Jul 20, 2025

Celularity Inc. Equity Warrant Stock Analysis and ForecastOutstanding capital growth - Autocar Professional

Jul 20, 2025

Jul 18, 2025

Will Celularity Inc. Equity Warrant stock benefit from AI tech trendsCarefully Curated High Return Stocks - Newser

Jul 18, 2025

Jul 17, 2025

Celularity Stock Surges Over 8% Amid Florida Stem Cell Policy, New Partnership Boost - AInvest

Jul 17, 2025

Jul 16, 2025

Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionInsider Strategy Insight - beatles.ru

Jul 16, 2025